SCHEMBL5454962

SCHEMBL5454962

CC(C)=CCCC(C)=CCCC(C)=CCOS(=O)(=S)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.50
MAPT P10636 2/20 0.47
PGR P06401 1/20 0.47
HTR1A P08908 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS1 P23219 1/20 0.47
PDE4A P27815 1/20 0.47
MAPK1 P28482 1/20 0.47
DRD3 P35462 1/20 0.47
SNCA P37840 1/20 0.47
PDE3A Q14432 1/20 0.47
FNTA P49354 3/20 0.45
FNTB P49356 3/20 0.45
ALOX15 P16050 2/20 0.44
LMNA P02545 2/20 0.43
ICMT O60725 1/20 0.43
GMNN O75496 1/20 0.43
TRPA1 O75762 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30218692 0.86 TRPV1 (0.52) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL15246439 0.86 TRPV1 (0.52) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL14815644 0.86 TRPV1 (0.52) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL21436889 0.85 TRPV1 (0.53) TRPV1MAPTPGRHTR1AADORA3
Squalene SCHEMBL23198699 0.79 KMT2A (0.55) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL7930022 0.76 MAPT (0.49) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL6463435 0.76 MAPT (0.49) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL2289564 0.76 MAPT (0.49) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL2236562 0.76 MAPT (0.49) TRPV1MAPTPGRHTR1AADORA3
SCHEMBL6028170 0.76 MAPT (0.49) TRPV1MAPTPGRHTR1AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637578-B2 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins ISIS INNOVATION LIMITED (GB) 2014-01-28 US disclosed
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins ISIS INNOVATION LIMITED (GB) 2007-09-13 US disclosed
EP-1644390-A2 REAGENTS AND METHODS FOR THE FORMATION OF DISULFIDE BONDS AND THE GLYCOSYLATION OF PROTEINS ISIS INNOVATION LIMITED (GB) 2006-04-12 EP disclosed
WO-2005000862-A2 REAGENTS AND METHODS FOR THE FORMATION OF DISULFIDE BONDS AND THE GLYCOSYLATION OF PROTEINS ISIS INNOVATION LIMITED (GB) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins SCLY, PTMS, TST TRPV1 4704/4885MAPT 3973/4885PGR 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.